A carregar...
Anti-VEGF therapy as adjuvant therapy: clouds on the horizon?
Anti-angiogenic therapies have demonstrated their value in the setting of advanced cancer, and are being explored for use in micrometastatic disease. Recent preclinical studies suggest that adjuvant anti-vascular endothelial growth factor (VEGF) therapies may increase the risk of metastasis. How con...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2716490/ https://ncbi.nlm.nih.gov/pubmed/19519950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2250 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|